These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 511350)
1. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides. Ortengren B; Fellner H; Bergan T Infection; 1979; 7 Suppl 4():S367-70. PubMed ID: 511350 [TBL] [Abstract][Full Text] [Related]
2. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim. Ekström B; Forsgren U; Ortengren B; Bergan T Infection; 1979; 7 Suppl 4():S359-66. PubMed ID: 389812 [TBL] [Abstract][Full Text] [Related]
3. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim. Ortengren B; Magni L; Bergan T Infection; 1979; 7 Suppl 4():S371-81. PubMed ID: 511351 [TBL] [Abstract][Full Text] [Related]
4. Co-trimazine distribution in the canine prostate. Frimodt-Möller N; Maigaard S; Madsen PO; Naber KG Infection; 1979; 7 Suppl 4():S345-8. PubMed ID: 511347 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility testing to trimethoprim alone and combined with sulphonamides. Dornbusch K; Gezelius L Chemotherapy; 1980; 26(6):418-26. PubMed ID: 7408555 [TBL] [Abstract][Full Text] [Related]
6. Comparative trial of sulphadiazine-trimethoprim (co-trimazine), co-trimoxazole and sulphamethizole in the treatment of uncomplicated urinary tract infections. Bailey RR; Pearson S N Z Med J; 1980 Jan; 91(652):43-4. PubMed ID: 6990320 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers. Garg SK; Ghosh SS; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):23-5. PubMed ID: 3485584 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole. Grey D; Hamilton-Miller JM J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of co-trimazine in vitro and in vivo. Ekström B; Fellner H; Forsgren U; Magni L; Ortengren B Infection; 1979; 7(2):74-80. PubMed ID: 374276 [TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of co-trimazine and co-trimoxazole in the urine. Acar J; Ekström B; Fellner H; Forsgren U; Guibert J; Huitfeldt B; Kitzis MD; Magni L; Ortengren B Infection; 1979; 7 Suppl 4():S324-9. PubMed ID: 389809 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function. Bergan T; Brodwall EK; Vik-Mo H; Anstad U Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352 [TBL] [Abstract][Full Text] [Related]
12. Some pharmacokinetic aspects of four sulphonamides and trimethoprim, and their therapeutic efficacy in experimental Escherichia coli infection in poultry. Goren E; de Jong WA; Doornenbal P Vet Q; 1984 Jul; 6(3):134-40. PubMed ID: 6385459 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of sulphonamides administered in combination with trimethoprim]. Klimowicz A Postepy Hig Med Dosw; 1992; 46(5):537-54. PubMed ID: 1298960 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Reeves DS; Wilkinson PJ Infection; 1979; 7 Suppl 4():S330-41. PubMed ID: 389810 [TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections. Skjerven O; Bergan T Infection; 1979; 7 Suppl 4():S398-400. PubMed ID: 389813 [TBL] [Abstract][Full Text] [Related]
17. A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections. Lövestad A; Gästrin B; Lundström R Infection; 1979; 7 Suppl 4():S401-3. PubMed ID: 389814 [TBL] [Abstract][Full Text] [Related]
18. Mutual inhibitory effect of (-)-mandelic acid and certain sulfonamides on the kinetics of their urinary excretion in humans. Kamienny FM; Barr M; Nagwekar JB J Pharm Sci; 1969 Nov; 58(11):1318-24. PubMed ID: 5349742 [No Abstract] [Full Text] [Related]
19. Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy. Seydel JK; Wempe E Infection; 1979; 7 Suppl 4():S313-20. PubMed ID: 389807 [No Abstract] [Full Text] [Related]
20. [Varying sensitivity of Gram-negative bacteria in the urine to nitrofurantoin itself, to combined nitrofurantoin-sulphadiazine and combined sulphonamide-trimethoprim (author's transl)]. Sixl-Voigt B; Brunner E Wien Klin Wochenschr; 1979 Mar; 91(7):218-21. PubMed ID: 433283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]